Shifeng Xue

Dr. Shifeng Xue

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2012 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
SXShifeng Xue
Shifeng Xue
MBMaria Barna
Maria Barna

1 April 2011 in Cell
Verified
Journal Article
Closed access
NKNadya Kondrashov
Nadya Kondrashov
APAya Pusic
Aya Pusic
CSCraig R. Stumpf
Craig R. Stumpf
KSKunihiko Shimizu
Kunihiko Shimizu
AHAndrew C. Hsieh
Andrew C. Hsieh
MBMaria Barna
Maria Barna

19 November 2014 in Nature
Verified
Journal Article
Open access
PDF file
SXShifeng Xue
Shifeng Xue
STSiqi Tian
Siqi Tian
KFKotaro Fujii
Kotaro Fujii
WKWipapat Kladwang
Wipapat Kladwang
RDRhiju Das
Rhiju Das
MBMaria Barna
Maria Barna
Emerging evidence suggests that the ribosome has a regulatory function in directing how the genome is translated in time and space. However, how this regulation is encoded in the messenger RNA sequence remains largely unknown. Here we uncover unique RNA regulons embedded in homeobox (Hox) 5′ untranslated regions (UTRs) that confer ribosome-mediated control of gene expression. These structured RNA elements, resembling viral internal ribosome entry sites (IRESs), are found in subsets of Hox mRNAs. They facilitate ribosome recruitment and require the ribosomal protein RPL38 for their activity. Despite numerous layers of Hox gene regulation, these IRES elements are essential for converting Hox transcripts into proteins to pattern the mammalian body plan. This specialized mode of IRES-dependent translation is enabled by an additional regulatory element that we term the translation inhibitory element (TIE), which blocks cap-dependent translation of transcripts. Together, these data uncover a new paradigm for ribosome-mediated control of gene expression and organismal development.

9 January 2017 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CGChristopher T Gordon
Christopher T Gordon
SXShifeng Xue
Shifeng Xue
GYGökhan Yigit
Gökhan Yigit
HFHicham Filali
Hicham Filali
KCKelan Chen
Kelan Chen
BRBruno Reversade
Bruno Reversade

13 June 2022 in Nature Methods
Verified
Journal Article
Closed access
PDF file
TNTram Anh Nguyen
Tram Anh Nguyen
JHJia Wei Joel Heng
Jia Wei Joel Heng
PKPornchai Kaewsapsak
Pornchai Kaewsapsak
EKEng Piew Louis Kok
Eng Piew Louis Kok
DSDominik Stanojević
Dominik Stanojević
MTMeng How Tan
Meng How Tan

30 January 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
CDCamille Dion
Camille Dion
SRStéphane Roche
Stéphane Roche
CLCamille Laberthonnière
Camille Laberthonnière
NBNatacha Broucqsault
Natacha Broucqsault
VMVirginie Mariot
Virginie Mariot
FMFrederique Magdinier
Frederique Magdinier
The DNA methylation epigenetic signature is a key determinant during development. Rules governing its establishment and maintenance remain elusive especially at repetitive sequences, which account for the majority of methylated CGs. DNA methylation is altered in a number of diseases including those linked to mutations in factors that modify chromatin. Among them, SMCHD1 (Structural Maintenance of Chromosomes Hinge Domain Containing 1) has been of major interest following identification of germline mutations in Facio-Scapulo-Humeral Dystrophy (FSHD) and in an unrelated developmental disorder, Bosma Arhinia Microphthalmia Syndrome (BAMS). By investigating why germline SMCHD1 mutations lead to these two different diseases, we uncovered a role for this factor in de novo methylation at the pluripotent stage. SMCHD1 is required for the dynamic methylation of the D4Z4 macrosatellite upon reprogramming but seems dispensable for methylation maintenance. We find that FSHD and BAMS patient's cells carrying SMCHD1 mutations are both permissive for DUX4 expression, a transcription factor whose regulation has been proposed as the main trigger for FSHD. These findings open new questions as to what is the true aetiology for FSHD, the epigenetic events associated with the disease thus calling the current model into question and opening new perspectives for understanding repetitive DNA sequences regulation.